Durezol difluprednate regulatory update

FDA accepted for filing an sNDA from Sirion for Durezol difluprednate to treat endogenous anterior uveitis. The PDUFA date is Oct. 24. The topical ophthalmic emulsion containing difluprednate is alrea...